Silver Book Fact

The excess economic burden of visual impairment and blindess of individuals age 40 and older on the individual, caregivers, and other health care payers is an estimated $5.48 billion annually– $5.12 billion in additional medical care expenditures and $360 million in informal care costs.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The average cost in 2004 per age-related macular degeneration (AMD) patient age 40 and older using medications and vitamins was $110.  
  • An estimated 1 million Americans over the age of 40 are legally blind.  
  • Glaucoma is responsible for 3 out of every 4 cases of visual impairment in the U.S.  
  • An estimated 2.3 million Americans 40 and older currently have glaucoma. That number is expected to grow by 50% to 3.36 million by 2020.  
  • Age-Related eye diseases affect more than 35 million Americans age 40 and older. The most common eye diseases in that age group are macular degeneration, glaucoma, diabetic retinopathy, and cataract.